Correlation Between Cogent Biosciences and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cogent Biosciences and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cogent Biosciences and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cogent Biosciences and Aerovate Therapeutics, you can compare the effects of market volatilities on Cogent Biosciences and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cogent Biosciences with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cogent Biosciences and Aerovate Therapeutics.
Diversification Opportunities for Cogent Biosciences and Aerovate Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cogent and Aerovate is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Cogent Biosciences and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Cogent Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cogent Biosciences are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Cogent Biosciences i.e., Cogent Biosciences and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Cogent Biosciences and Aerovate Therapeutics
Given the investment horizon of 90 days Cogent Biosciences is expected to generate 0.85 times more return on investment than Aerovate Therapeutics. However, Cogent Biosciences is 1.17 times less risky than Aerovate Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 1,250 in Cogent Biosciences on August 24, 2024 and sell it today you would lose (337.00) from holding Cogent Biosciences or give up 26.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cogent Biosciences vs. Aerovate Therapeutics
Performance |
| Timeline |
| Cogent Biosciences |
| Aerovate Therapeutics |
Cogent Biosciences and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cogent Biosciences and Aerovate Therapeutics
The main advantage of trading using opposite Cogent Biosciences and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cogent Biosciences position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Cogent Biosciences vs. Larimar Therapeutics | Cogent Biosciences vs. Kura Oncology | Cogent Biosciences vs. Kiniksa Pharmaceuticals | Cogent Biosciences vs. Ideaya Biosciences |
| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Correlations Find global opportunities by holding instruments from different markets |